BioOutsource Opens New Facility in Glasgow

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-08-05-2015
Volume 11
Issue 8

The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.

BioOutsource, part of Sartorius Stedim Biotech Group, has opened a new facility in Glasgow. The investment follows the increasing demand for the company’s biologics contract testing and biosimilar characterization services. The new facility doubles BioOutsource’s capacity for future growth and will create approximately 50 new jobs for scientific and technical professionals in the next six months, according to the company.

Source: BioOutsource

Articles in this issue
Figures1-New-1438610917643.gif
CDMOs Move Slowly with Expansion Plans
Accelerating Continuous API Synthesis
Accelerating Continuous API Synthesis
BioOutsource Opens New Facility in Glasgow
Needle in the Haystack, or Rembrandt in the Attic? Drug Repurposing's New Strategy
Silicone Rubber Pieces Spur Recall of Teva Product
Baxter Recalls IV Solution for Container and Particulate Issues
Indian API Manufacturer Cited for Recordkeeping Failures
Xcelience Makes Investment in Powdersize
FDA Issues Quality Metrics Draft Guidance Document for Comment
EMA Issues Guideline on Fast Tracking Drugs for Unmet Needs
SafeBridge Updates Potent API and Drug Manufacturer Status
Capsugel Expands Capabilities at its Edinburgh Facility
DPx Holdings Sells Fine Chemicals Business
World Courier Receives UK Wholesale Distribution Authorisation
CSafe Adds Service Center for Controlled-Temperature Shipping in Switzerland
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines, episode 7
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

AbbVie to Boost Immunology Pipeline with Acquisition of Nimble Therapeutics

Feliza Mirasol
December 18th 2024
Article

AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Several Orphan Drugs Among Medicines Recommended for Approval by EMA in December

Susan Haigney
December 16th 2024
Article

EMA recommended 17 drugs for marketing authorization in December, including treatments for rare heart conditions, anemia, and liver disease.